Table 2.
1. | 2. | 3. | 4. | 5. | 6. | 7. | 8. | 9. | |
---|---|---|---|---|---|---|---|---|---|
1. Age | – | ||||||||
2. BMI | 0.03 | – | |||||||
3. Pain duration | 0.03 | 0.03 | – | ||||||
4. Opioid use | 0.17 | 0.10 | −0.14 | – | |||||
5. NPRS | −0.01 | 0.21 | −0.08 | 0.03 | – | ||||
6. PCS | 0.09 | 0.20 | 0.05 | −0.05 | 0.38* | – | |||
7. CPAQ | −0.07 | −0.19 | −0.07 | 0.01 | −0.39* | −0.52* | – | ||
8. TSK | 0.12 | 0.26* | 0.09 | 0.06 | 0.46* | 0.55* | −0.64* | – | |
9. PF-FIQR | 0.06 | 0.031 | −0.03 | 0.04 | 0.35* | 0.44* | −0.50* | 0.54* | - |
10. 6MWT | −0.87 | −0.16 | −0.02 | −0.12 | −0.40 | −0.57* | 0.54* | −0.70* | −0.54* |
Note: *Bonferroni adjusted 2-sided significance level of α ≤ 0.05/10= p ≤ 0.005.
Abbreviations: BMI, Body Mass Index; NPRS, Numeric Pain Rating Scale; PCS, Pain Catastrophizing Scale; CPAQ, Chronic Pain Acceptance Questionnaire; TSK, Tampa Scale of Kinesiophobia; PF-FIQ, Physical Functioning subscale of the Fibromyalgia Impact Questionnaire; 6MWT, 6 Minute Walking Test.